MedTrace Logo

Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation

NCT06681116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 325

Last updated 2024-11-08

No results posted yet for this study

Summary

We assessed the effect of structured nano-water in the prevention of recurrent stone formation in patients with recurrent calcium oxalate stones and hypercalciuria.

Conditions

  • Renal Stones
  • Idiopathic Hypercalciuria

Interventions

DIETARY_SUPPLEMENT

structured nano-water

Hydrochlorothiazide is a drug used to prevent recurrent renal stone formation in patients with idiopathic hypercalciuria

DRUG

Hydrochlorothiazide (HCTZ)

hydrochlorothiazide is a drug used to prevent recurrent stone formation i patients with idiopathic hypercalciuria

OTHER

ordinary bottled drinking water

Patients with idiopathic hypercalciuria receiving regular bottled drinking water as a placebo to see its effect.

Sponsors & Collaborators

  • ALI KAMAL M. SAMI

    lead OTHER

Principal Investigators

  • Ali K M. Sami, MBChB FIBMS · College of Medicine, University of Sulaimani

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-16
Primary Completion
2020-08-24
Completion
2020-08-24

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06681116 on ClinicalTrials.gov